Bader M - Search Results

1

Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension.

Grabowski K, Herlan L, Witten A, Qadri F, Eisenreich A, Lindner D, Schädlich M, Schulz A, Subrova J, Mhatre KN, Primessnig U, Plehm R, van Linthout S, Escher F, Bader M, Stoll M, Westermann D, Heinzel FR, Kreutz R. Grabowski K, et al. Among authors: bader m. Hypertens Res. 2022 Feb;45(2):292-307. doi: 10.1038/s41440-021-00826-8. Epub 2021 Dec 16. Hypertens Res. 2022. PMID: 34916661 Free PMC article.

2

Progress in molecular medicine. From experimental genetics to the treatment of hypertensive patients.

Ganten D, Kreutz R, Bader M, Wagner J. Ganten D, et al. Among authors: bader m. Chin Med J (Engl). 1993 May;106(5):375-84. Chin Med J (Engl). 1993. PMID: 8404282 Review. No abstract available.

3

Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.

Böhm M, Lee M, Kreutz R, Kim S, Schinke M, Djavidani B, Wagner J, Kaling M, Wienen W, Bader M, et al. Böhm M, et al. Among authors: bader m. J Hypertens. 1995 Aug;13(8):891-9. doi: 10.1097/00004872-199508000-00010. J Hypertens. 1995. PMID: 8557967

4

The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy.

Baltatu O, Silva JA Jr, Ganten D, Bader M. Baltatu O, et al. Among authors: bader m. Hypertension. 2000 Jan;35(1 Pt 2):409-12. doi: 10.1161/01.hyp.35.1.409. Hypertension. 2000. PMID: 10642333

5

Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene.

Silva JA Jr, Araujo RC, Baltatu O, Oliveira SM, Tschöpe C, Fink E, Hoffmann S, Plehm R, Chai KX, Chao L, Chao J, Ganten D, Pesquero JB, Bader M. Silva JA Jr, et al. Among authors: bader m. FASEB J. 2000 Oct;14(13):1858-60. doi: 10.1096/fj.99-1010fje. FASEB J. 2000. PMID: 11023967

6

Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen.

Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D, Bader M. Baltatu O, et al. Among authors: bader m. Hypertension. 2001 Feb;37(2 Pt 2):408-13. doi: 10.1161/01.hyp.37.2.408. Hypertension. 2001. PMID: 11230309

7

Normal blood pressure and renal function in mice lacking the bradykinin B(2) receptor.

Milia AF, Gross V, Plehm R, De Silva JA Jr, Bader M, Luft FC. Milia AF, et al. Among authors: bader m. Hypertension. 2001 Jun;37(6):1473-9. doi: 10.1161/01.hyp.37.6.1473. Hypertension. 2001. PMID: 11408397

8

Abolition of end-organ damage by antiandrogen treatment in female hypertensive transgenic rats.

Baltatu O, Cayla C, Iliescu R, Andreev D, Bader M. Baltatu O, et al. Among authors: bader m. Hypertension. 2003 Mar;41(3 Pt 2):830-3. doi: 10.1161/01.HYP.0000048702.55183.89. Epub 2002 Dec 16. Hypertension. 2003. PMID: 12624004

9

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.

Tschöpe C, Walther T, Königer J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M. Tschöpe C, et al. Among authors: bader m. FASEB J. 2004 May;18(7):828-35. doi: 10.1096/fj.03-0736com. FASEB J. 2004. PMID: 15117887

10

Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene.

Tschöpe C, Spillmann F, Rehfeld U, Koch M, Westermann D, Altmann C, Dendorfer A, Walther T, Bader M, Paul M, Schultheiss HP, Vetter R. Tschöpe C, et al. Among authors: bader m. FASEB J. 2004 Dec;18(15):1967-9. doi: 10.1096/fj.04-1614fje. Epub 2004 Sep 24. FASEB J. 2004. PMID: 15448111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,594 results

Search Page